Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology. 2013 May; 144(5):1098-106.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.